Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases, ...

Company Adopts New Protocol Across All 176 Clinics to Enhance Non-Surgical Pain Relief QC Kinetix, the leading regenerative medicine provider in the U.S., is raising the standard for non-surgical ...

Company Adopts New Protocol Across All 176 Clinics to Enhance Non-Surgical Pain Relief CHARLOTTE, N.C., April 09, 2025--(BUSINESS WIRE)--QC Kinetix, the leading regenerative medicine provider in ...

Today, Mirvie announced results of a breakthrough study published in Nature Communications, revealing new advances in the biological ... Dr. Kara Rood, maternal-fetal medicine physician, one ...

Congress established the biotechnology commission in 2021 to ... growing ascendance in biotech threatens more than American medical advances, because the technology could give China advantages ...

Now, in new research, scientists at the Lewis Katz School of Medicine at Temple University have discovered a novel regulator of NCLX activity, a protein called TMEM65, which helps move calcium out ...

Successful collaborations are built on open communication and a shared commitment to both risks and rewards. These ...

The field of genetics is advancing dramatically and with these advances the prospect of true personalised medicine become increasingly more real. This brings hope to those with rare diseases where ...

State Key Laboratory of Luminescent Materials and Devices, Guangdong Provincial Key Laboratory of Luminescence from Molecular Aggregates Center for Aggregation-Induced Emission, South China University ...

AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company, in collaboration with the Telethon Institute of Genetics and Medicine (TIGEM), announces the publication of their preclinical ...

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...

PDS Biotechnology Corp (NASDAQ ... A: (Kirk Shepard, Chief Medical Officer) We initiated the first site this month, and almost all sites from the phase 2 trial are re-engaged for phase 3, which ...